Usefulness of ceftazidime and imipenem for the treatment of Pseudomonas aeruginosa meningitis. Study of 3 patients
Aguirrebengoa, L.; Montejo, M.; Urkijo, J.C.; Pérez-Escajadillo, J.; Hernández-Almaraz, J.L.; Aguirre, C.
Enfermedades Infecciosas y Microbiologia Clinica 7(4): 224-225
1989
ISSN/ISBN: 0213-005X PMID: 2490706 Document Number: 333056
Document emailed within 1 workday
Related Documents
Pruekprasert, P.; Tunyapanit, W. 2005: In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa Southeast Asian Journal of Tropical Medicine and Public Health 36(5): 1239-1242Sader; Cerbara; Luz; Hashimoto 1999: Evaluation of the Cephalosporins, Cefepime, Cefpirome and Ceftazidime, against Clinical Isolates of Imipenem-Resistant Pseudomonas aeruginosa Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(6): 231-237
Sze, E.H.; Osborne, N.G.; Adelson, M.D.; Granato, P. 1988: Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma Journal of the National Medical Association 80(10): 1133-1135
Mikasa, K.; Sawaki, M.; Konishi, M.; Narita, N. 1990: Clinical efficacy of imipenem/cilastatin sodium in patients with respiratory tract infections caused by Pseudomonas aeruginosa Japanese Journal of Antibiotics 43(1): 9-13
Dilmen, U.; Kanra, G.; Yilgör, E.; Ozsoylu, S. 1983: Netilmicin in the treatment of Pseudomonas aeruginosa meningitis Turkish Journal of Pediatrics 25(1): 59-62
Michel-Briand, Y.; Nicolas, T.; Godard, C.; Plesiat, P. 1992: Beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains Microbiologica 15(1): 65-69
Maugein, J.; Fourche, J.; Pellegrin, J.L.; Mormède, M. 1990: Effect of various technics in the determination of sensitivity of Pseudomonas aeruginosa to imipenem Pathologie-Biologie 38(5): 362-365
Carlone, N.; Ferrero, M.; Cuffini, A.; Cavallo, G. 1987: Ultrastructural modifications induced by imipenem and their implications in the pathogenicity of Pseudomonas aeruginosa Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 73-74
Palkina, N.A.; Bulk, V.F.; Zhvanetskaia, M.I.; Stakislavskiĭ, E.S.; Kolker, I.I. 1978: Immunological study of cellular components of Pseudomonas aeruginosa. IV. Fractionation of Pseudomonas aeruginosa mucus by diafiltration and biological properties of isolated fractions Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 50-55
Aguilar, L.; Giménez, M.J.; Martín, J.E.; Prieto, J. 2005: Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration? Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 18(1): 21-25
García-Rodríguez, J.A.; García Sánchez, J.E.; Muñoz Bellido, J.L.; García Sánchez, E.; García García, M.I. 1991: In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia Journal of ChemoTherapy 3(3): 143-146
Drenjancević, D.; Vranes, J.; Bedenić, B.; Sakić-Zdravcević, K. 2007: In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains Collegium Antropologicum 31(1): 221-225
Naenna, P.; Noisumdaeng, P.; Pongpech, P.; Tribuddharat, C. 2010: Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates Southeast Asian Journal of Tropical Medicine and Public Health 41(3): 614-624
Mimoz, O.; Jacolot, A.; Leotard, S.; Hidri, N.; Samii, K.; Nordmann, P.; Petitjean, O. 1998: Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains Antimicrobial Agents and ChemoTherapy 42(12): 3304-3308
Gobernado, M. 1998: Active drugs against Pseudomonas aeruginosa and their clinical usefulness Revista Clinica Espanola 198(Suppl 2): 51-61
Batlle Almodóvar, M.ía.d.C.; Dickinson, F.él.; Pérez Monrás, M.; Tamargo Martínez, I.; Similis, A. 2005: Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case Revista Cubana de Medicina Tropical 57(3): 230-232
Nartowicz, A.; Slowik, J. 1975: Cerebrospinal meningitis in a 2-1/2-year-old child caused by Pseudomonas aeruginosa Pediatria Polska 50(12): 1501-1503
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
Baltch, A.L.; Griffin, P.E. 1977: Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients American Journal of the Medical Sciences 274(2): 119-129